Clients
Recent News
12/21/2016
Pfizer makes a $6 million equity investment in new shares in BioInvent
Lund, Sweden – 21 December 2016
 »
12/13/2016
Acer Therapeutics obtains exclusive rights to NDA-enabling clinical data of the company’s lead product, VASEBRA™ (celiprolol), for the treatment of vascular Ehlers-Danlos Syndrome (vEDS)
 »
10/20/2016
Catalyst Biosciences Announces Agreement to Sell NNR Asset
 »
10/20/2016

Jacobs, Stratasys Partner to Advance Medical 3D Printing

 »